Compare Medpace Holdings Inc (MEDP) vs TotalEnergies SE (TTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs TotalEnergies SE — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while TotalEnergies SE trades at $86.11 (market cap $191.82B). The key difference: TotalEnergies SE is far larger — about 11.4× Medpace Holdings Inc's market cap, and TotalEnergies SE pays a 4.93% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and TotalEnergies SE for 90 Days on average.
| MEDP | TTE | |
|---|---|---|
Market Cap | $16.82B | $191.82B |
Volume | 223,093 | 3,311,339 |
Sector | Health | Energy |
52-Week High | $630.19 | $93.60 |
52-Week Low | $393.42 | $57.39 |
Typical Hold Time | 14 Days | 90 Days |
Enterprise Value | $16.44B | $222.81B |
Dividend Yield | — | 4.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $602.70, down 0.26% with neutral technical signals. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (17.67% net margin, 162.15% ROE). Recent CEO stock sales and mixed institutional activity create near-term uncertainty, though analyst consensus remains positive with a $620.44 price target. The company is scheduled to report Q3 2026 results on October 21, 2026.
MEDP presents a compelling growth story with strong financial metrics, though elevated valuations (P/E 35.41) and insider selling warrant caution. Upside potential exists if Q3 earnings meet expectations, while failure to maintain growth momentum could pressure the stock. The current price near pivot point ($599) suggests balanced risk-reward ahead of earnings.
TotalEnergies (TTE) trades at $86.02, up 2.13% today, with a bearish technical signal but strong fundamentals including a P/E of 10.77 and ROE of 14.56%. Recent earnings beat expectations in Q1 and Q2 2026, and the company announced a $10 billion investment in Argentina and increased share buybacks to $2.5 billion, signaling growth commitment. Cash flow trends show a recovery to positive net cash flow in 2025 after declines in prior years.
The outlook is positive with a consensus price target of $95.33, representing 10.8% upside, supported by 55.88% analyst buy ratings. Risks include declining revenue from $263.3B in 2022 to $182.3B in 2025 and rising debt-to-asset ratio to 20.17% in 2025. Strategic investments in LNG and power diversification offer long-term growth, but oil price volatility and execution risks remain key concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →
